BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36472850)

  • 1. PARP1 and OGG1 in Medicated Patients With Depression and the Response to ECT.
    Ryan KM; McLoughlin DM
    Int J Neuropsychopharmacol; 2023 Feb; 26(2):107-115. PubMed ID: 36472850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative DNA damage and reduced expression of DNA repair genes: Role in primary open angle glaucoma (POAG).
    Mohanty K; Dada R; Dada T
    Ophthalmic Genet; 2017; 38(5):446-450. PubMed ID: 28129013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of PARP1 transcription by CDK4/6 inhibitors sensitizes human lung cancer cells to anticancer drug-induced death by impairing OGG1-dependent base excision repair.
    Tempka D; Tokarz P; Chmielewska K; Kluska M; Pietrzak J; Rygielska Ż; Virág L; Robaszkiewicz A
    Redox Biol; 2018 May; 15():316-326. PubMed ID: 29306194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered DNA base excision repair profile in brain tissue and blood in Alzheimer's disease.
    Lillenes MS; Rabano A; Støen M; Riaz T; Misaghian D; Møllersen L; Esbensen Y; Günther CC; Selnes P; Stenset VT; Fladby T; Tønjum T
    Mol Brain; 2016 May; 9(1):61. PubMed ID: 27234294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OGG1-initiated base excision repair exacerbates oxidative stress-induced parthanatos.
    Wang R; Li C; Qiao P; Xue Y; Zheng X; Chen H; Zeng X; Liu W; Boldogh I; Ba X
    Cell Death Dis; 2018 May; 9(6):628. PubMed ID: 29795387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of selective serotonin reuptake inhibitors on DNA damage in patients with depression.
    Ahmadimanesh M; Abbaszadegan MR; Morshedi Rad D; Moallem SA; Mohammadpour AH; Ghahremani MH; Farid Hosseini F; Behdani F; Akhondpour Manteghi A; Jowsey P; Shabani Behbahani F; Moallem SMH; Etemad L
    J Psychopharmacol; 2019 Nov; 33(11):1364-1376. PubMed ID: 31556787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of APE1 T2197G (Asp148Glu) polymorphism on APE1, XRCC1, PARP1 and OGG1 expression in patients with colorectal cancer.
    Santos JC; Funck A; Silva-Fernandes IJ; Rabenhorst SH; Martinez CA; Ribeiro ML
    Int J Mol Sci; 2014 Sep; 15(10):17333-43. PubMed ID: 25268610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient OGG1, APE1, PARP1 and Polβ expression in an Alzheimer's disease mouse model.
    Lillenes MS; Støen M; Gómez-Muñoz M; Torp R; Günther CC; Nilsson LN; Tønjum T
    Mech Ageing Dev; 2013 Oct; 134(10):467-77. PubMed ID: 24121118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Circulating Levels of GR, FKBP5, and SGK1 in Medicated Patients With Depression Are Not Altered by Electroconvulsive Therapy.
    Ryan KM; Poelz L; McLoughlin DM
    J ECT; 2020 Jun; 36(2):137-143. PubMed ID: 31725056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting OGG1 arrests cancer cell proliferation by inducing replication stress.
    Visnes T; Benítez-Buelga C; Cázares-Körner A; Sanjiv K; Hanna BMF; Mortusewicz O; Rajagopal V; Albers JJ; Hagey DW; Bekkhus T; Eshtad S; Baquero JM; Masuyer G; Wallner O; Müller S; Pham T; Göktürk C; Rasti A; Suman S; Torres-Ruiz R; Sarno A; Wiita E; Homan EJ; Karsten S; Marimuthu K; Michel M; Koolmeister T; Scobie M; Loseva O; Almlöf I; Unterlass JE; Pettke A; Boström J; Pandey M; Gad H; Herr P; Jemth AS; El Andaloussi S; Kalderén C; Rodriguez-Perales S; Benítez J; Krokan HE; Altun M; Stenmark P; Berglund UW; Helleday T
    Nucleic Acids Res; 2020 Dec; 48(21):12234-12251. PubMed ID: 33211885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor gamma co-activator-1 alpha in depression and the response to electroconvulsive therapy.
    Ryan KM; Patterson I; McLoughlin DM
    Psychol Med; 2019 Aug; 49(11):1859-1868. PubMed ID: 30191781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease-associated polymorphisms in human OGG1 alter catalytic activity and sensitize cells to DNA damage.
    Jacob KD; Noren Hooten N; Tadokoro T; Lohani A; Barnes J; Evans MK
    Free Radic Biol Med; 2013 Oct; 63():115-25. PubMed ID: 23684897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of base excision repair key factors and miR17 in familial and sporadic breast cancer.
    De Summa S; Pinto R; Pilato B; Sambiasi D; Porcelli L; Guida G; Mattioli E; Paradiso A; Merla G; Micale L; De Nittis P; Tommasi S
    Cell Death Dis; 2014 Feb; 5(2):e1076. PubMed ID: 24556691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ADP-ribose) polymerase 1 (PARP1) promotes oxidative stress-induced association of Cockayne syndrome group B protein with chromatin.
    Boetefuer EL; Lake RJ; Dreval K; Fan HY
    J Biol Chem; 2018 Nov; 293(46):17863-17874. PubMed ID: 30266807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PARP1 Gene Knockout Suppresses Expression of DNA Base Excision Repair Genes.
    Zakharenko AL; Malakhova AA; Dyrkheeva NS; Okorokova LS; Medvedev SP; Zakian SM; Kabilov MR; Tupikin AA; Lavrik OI
    Dokl Biochem Biophys; 2023 Feb; 508(1):6-11. PubMed ID: 36653586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ADP-ribose) polymerase 1 (PARP-1) binds to 8-oxoguanine-DNA glycosylase (OGG1).
    Noren Hooten N; Kompaniez K; Barnes J; Lohani A; Evans MK
    J Biol Chem; 2011 Dec; 286(52):44679-90. PubMed ID: 22057269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced cytarabine-induced killing in OGG1-deficient acute myeloid leukemia cells.
    Owen N; Minko IG; Moellmer SA; Cammann SK; Lloyd RS; McCullough AK
    Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective Base Excision Repair of Oxidative DNA Damage in Vascular Smooth Muscle Cells Promotes Atherosclerosis.
    Shah A; Gray K; Figg N; Finigan A; Starks L; Bennett M
    Circulation; 2018 Oct; 138(14):1446-1462. PubMed ID: 29643057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulation of base excision repair gene expression and enhanced proliferation in head and neck squamous cell carcinoma.
    Mahjabeen I; Ali K; Zhou X; Kayani MA
    Tumour Biol; 2014 Jun; 35(6):5971-83. PubMed ID: 24622884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone.
    Chakrabarti G; Silvers MA; Ilcheva M; Liu Y; Moore ZR; Luo X; Gao J; Anderson G; Liu L; Sarode V; Gerber DE; Burma S; DeBerardinis RJ; Gerson SL; Boothman DA
    Sci Rep; 2015 Nov; 5():17066. PubMed ID: 26602448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.